The CNS neurotransmitter GABA is distributed extensively throughout the suprachiasmatic nucleus, the site of circadian pacemaker cells in mammals.
Circadian rhythms in mammals exhibit free-running periods of about 24 hr in the absence of environmental time cues. Synchronization with 24-hr light-dark (LD) cycles is thought to occur primarily through daily phase shifts of the endogenous rhythm, achieved by interaction between the photic signals and the circadian clock (Pittendrigh, 1960; DeCoursey, 1964) .
The hypothalamic suprachiasmatic nucleus (SCN) is the site of a circadian clock in mammals. The evidence that supports this has been reviewed extensively (see Moore, 1983; Klein et al., 1991; Ralph and Lehman, 1991) . However, within the SCN, the neurochemical mechanisms underlying circadian rhythm generation and responses to light are not well understood. The photic entrainment pathway originates in ganglion cells of the retina, whose axons form a retinohypothalamic tract (RHT) that terminates in the SCN (Moore and Lenn, 1972) . There is some evidence that the RHT utilizes glutamate as a neurotransmitter, acting through N-methyl-D-aspartate (NMDA) and non-NMDA receptors (Abe et al., 1992; Colwell and Menaker, 1992) . A second, multisynaptic pathway, which includes the intergeniculate leaflet (IGL) of the thalamus and receives light input (Harrington and Rusak, 1989) , may also carry some photic information to the SCN via the geniculohypothalamic tract (GHT) (Zhang and Rusak, 1989 ; for a review, see Meijer and Rietveld, 1989 ). These axons travel in the optic tract and exhibit neuropeptide Y and GABA immunoreactivity (Michels et al., 1990) .
The most widely represented neurotransmitter in the SCN is GABA (Michels et al., 1990 ; Moore and Speh, 1993 ), yet little is known about its function in rhythm generation and entrainment. Direct application of GABA or of its agonists and antagonists demonstrates an inhibitory effect of this neurotransmitter on the electrophysiological properties of SCN neurons in vitro Mason et al., 1991; Kim and Dudek, 1992). Pharmacological manipulations in vivo alter specific circadian responses to light. Bicuculline, an antagonist at the GABAA receptor, blocks light-induced phase delays Menaker, 1985, 1989) , whereas diazepam, which potentiates GABA activity through the benzodiazepine site on the same receptor, blocks phase advances Menaker, 1986, 1989) . Some benzodiazepines (triazolam, Turek and Van Reeth, 1988; chlordiazepoxide, Biello et al., 1991; Biello and Mrosovsky, 1993) and GABAA agonists (muscimol, Smith et al., 1989 Smith et al., , 1990 produce phase shifts of free-running rhythms in hamsters.
Together, these results indicate a role for GABA in the regulation of circadian rhythms and entrainment to light cycles. However, the nature of this role is not clear. First, the site of action for some GABA active agents is not necessarily within the SCN. Effects of some benzodiazepines, for example, require behavioral activation (Van Reeth and Mrosovsky and Salmon, 1990) . Second, although previous reports suggest an involvement of GABA and its receptors in modulating circadian photic responses, the results are complex and do not support a classic, chloride-mediated function. In fact, the inability to mimic effects of bicuculline with the chloride channel antagonist picrotoxin, along with the general ineffectiveness of GABA agonists to alter photic responses (Ralph and Menaker, 1989) , calls into question the functional role of endogenous SCN GABA in rhythm generation and entrainment.
We have suggested previously that a phase-dependent modulation of GABA release may be important in setting the relative responsiveness of the circadian system in the early and late subjective night, thereby contributing to entrainment characteristics (Ralph and Menaker, 1989) . To test this hypothesis, we have used a GABA transaminase inhibitor, vigabatrin (y-vinyl GABA), which has been shown to increase the CNS levels of this neurotransmitter either chronically or acutely (Jung et al., 1977; Schechter, 1984; Beart et al., 1985; Hammond and Wilder, 1985; Loscher, 1986; Halonen et al., 1991) . Since major central effects of vigabatrin rely on the release of GABA (among other actions; see &dquo;Discus-sion&dquo;), alterations in circadian rhythms or responses to light could be interpreted in terms of the role of this inhibitory neurotransmitter in SCN regulation.
MATERIALS AND METHODS
Male golden hamsters (Charles River, St. Constant, Quebec ; 45-60 days old at the beginning of the experiment) were housed individually in cages provided with a 17-cm-diameter running wheel, and their locomotor activity was recorded with Dataquest III (Minimitter, Sunriver, OR). The animals were exposed initially to LD 14:10.
The onsets of activity (defined as circadian time 12 [CT 12]) in each circadian cycle were used as phase markers to calculate phase shifts to light pulses in constant darkness (DD). Light pulses (~-700 lux, Gossen Lunasix Meter, measured inside the cage) were administered at the times of maximum responsiveness determined previously for the hamster: CT 13.5 for delays and CT 18 for advances. Phase shifts were calculated by means of eyefitted lines through consecutive onsets of activity. Lines through the 7 days prior to the day of a pulse and/or injection, and through the onsets of days 4-10 postpulse, were extrapolated to CT 12 on day 1 (the day following the manipulation). The phase shift was defined as the difference between the timing for CT 12 on day 1 as projected by the prepulse and the postpulse lines. Free-running periods were determined from the slope of eye-fitted lines drawn through onsets on days 4-12 in any given condition (day 1 being the day of implantation or start of condition).
EXPERIMENT l: liGHT-INDUCED PHASE SHIFTS
Hamsters were maintained in constant conditions (DD) throughout the experiment. After a stable free-running period was attained, the animals were given an intraperitoneal injection of either sterile saline (0.5 ml) or vigabatrin (250 mg/kg in 0.5 ml saline) 60 min before the projected time for light pulses. At CT 13.5 (n = 13) or CT 18 (n = 6), the hamsters received a 15-min light pulse and were returned to DD. From 10 to 14 days later, the animals were injected a second time with vigabatrin or vehicle in a crossover design at the same CTs as before; that is, the &dquo;delay&dquo; and &dquo;advance&dquo; groups were maintained, and the injections were done 1 hr before the light pulses. After another 10-14 days, the phase shifts were calculated and compared. A dark control group (n = 5) received vigabatrin injections alone at CT 13.5 and CT 18 (that were not followed by light pulses). The vigabatrin was a generous gift from Nordic Merrel Dow Recherche, Laval, Quebec.
EXPERIMENT 2 : FREE-RUNNING PERIOD IN DD
In order to test whether the level of endogenously released GABA influenced the production of circadian rhythms, animals were chronically infused with vigabatrin. After at least 10 days in DD during which the free-running period was determined, animals were implanted with 200-ml osmotic minipumps (model 2002; Alza Co., Palo Alto, CA). Each pump was filled with 90 mg of vigabatrin dissolved in 200 ml saline. The minipumps deliver 0.5 ml/ hr for 14 days, so the animals would have received 1000 mg/kg in 2 weeks. Eight animals were implanted with vigabatrin-filled pumps; two were implanted with saline-filled pumps; and two were used as intact controls. For implantation, each hamster was anesthetized with 80 mg/kg sodium pentobarbital. An incision was made in the abdomen, and the pump was placed inside the peritoneal cavity. The incision was then sutured, and the animal was placed again in DD. After 14 days, the actograms were analyzed to check whether there had been any period change between pre-and postsurgery. On day 15 postsurgery, hamsters received light pulses at either CT 13.5 (n = 4) or CT 18 (n = 4), to determine whether photic responses had been altered.
EXPERIMENT 3 : FREE-RUNNING PERIOD IN CONSTANT LIGHT As the results from Experiments 1 and 2 showed that vigabatrin treatment affected lightinduced phase delays and advances differentially, we determined whether animals with constant vigabatrin infusion would experience changes in period under constant light (LL). After entrainment in an LD cycle, hamsters were placed in LL conditions (150 lux). After 26 days in LL, seven animals were implanted with osmotic minipumps filled with 90 mg vigabatrin in 200 ml saline; three animals received saline-filled pumps; and two animals were kept as intact controls. Surgery was the same as that for Experiment 2. Animals were maintained in LL for an additional 30 days. Periods were calculated from eye-fitted lines through activity onsets and were confirmed with periodogram analysis.
RESULTS
Actograms of representative animals that received light pulses at CT 13.5 or CT 18 in Experiment 1 are shown in Figure 1 . Light pulses that followed saline injection induced phase delays of -79 ± 6.3 min (SEM) at CT 13.5, and phase advances of + 112.5 ± 22 min at CT 18. When the same animals received the vigabatrin injection, photic-induced phase delays were increased significantly ( -136 .6 -~-19 min; p < 0.005, Student's t test), whereas advances were approximately the same as those of controls ( + 102.5 ± 18 min; FIGURE 1. Actograms showing the locomotor activity rhythm of hamsters in DD. Horizontal arrows indicate days of injection; stars indicate injection times. Control saline (s) or 250 mg/kg vigabatrin in saline (v) injections were followed by 15-min light pulses at CT 13.5 (left panels) or CT 18 (right panels), producing the corresponding phase delays or advances. p > 0.5) (Fig. 2) . No significant order effect or systematic effect of duration in DD was detected. Vigabatrin did not produce phase shifts when applied in the absence of light at either CT 13.5 ( + 8 -~ 2 min, n = 4) or CT (+ 10 ± 4 min, n = 4).
In Experiment 2, the period of the wheel-running locomotor activity rhythm in DD was not affected by the chronic infusion of vigabatrin. Comparison of periods before and during infusion revealed no significant change in the group's mean (p > 0.4, Student's t test) and no trend among individuals (p > 0.21, Wilcoxon signed-rank test). However, when these animals were given a light pulse following 14 days of infusion, phase delays were greatly increased in the vigabatrin group ( -162 ± 6 min) over the saline controls ( -94.2 ± 8 min) ( Figs. 3 and 4 ; p < 0.02, t test). Advances were approximately the same magnitude in the two groups (vigabatrin, + 151.8 ± 29 min; control, + 156 ± 24 min) ( Figs. 3 and 4) .
In Experiment 3, chronic vigabatrin treatment increased the period of the locomotor activity rhythm in LL, as compared with intact or saline-treated animals (Figs. 5 and 6). Six out of the seven animals showed an increased period, resulting in a statistically significant effect of vigabatrin (24.51 ± 0.08 hr vs. 24.26 ± 0.08 hr; p < 0.03, one-tailed t test). Animals were maintained in LL for an additional 2 weeks following the projected life of the pumps (i.e., 15 days after implantation). During this last period of time, circadian period in vigabatrin-treated animals shortened significantly, reaching original LL values (Figs. 5 and 6). Neither saline-treated nor untreated animals showed period lengthening and shortening over the same time interval.
DISCUSSION
A role for GABA in the regulation of mammalian circadian rhythms is suggested by a variety of anatomical and pharmacological evidence. In the studies described here, we used a GABA transaminase inhibitor, vigabatrin, and assessed its effects on rhythmicity in the hamster. FIGURE 2. Average phase-shift responses to light in control and vigabatrin-treated animals. Vigabatrin significantly increased the response at CT 13.5 (*p < 0.005, Student's t test). FIGURE 3. Actograms of animals in DD that were implanted with osmotic minipumps containing saline (A, C) or vigabatrin (B, D) on day marked &dquo;I.&dquo; The period of the wheel-running rhythm was unaffected. Animals were exposed 15 days later (on days indicated by arrows) to a 15-min light pulse at either CT 18 (A, B) or CT 13.5 (C, D).
Vigabatrin has been shown previously to increase GABA concentrations in the CNS following single injection (Jung et al., 1977; Schechter, 1984; Halonen et al., 1991) or during chronic infusion (Beart et al., 1985; Loscher, 1986) .
The effect of this treatment on the circadian system was a preferential enhancement of phase delays induced by light at CT 13.5, following either single injections of the drug (Experiment 1) or 14 days of continuous infusion (Experiment 2). This was confirmed by the period lengthening produced by chronic vigabatrin administration in LL (Experiment 3). As light is present at all points of the circadian cycle in LL, a selective increase in the delaying responses would be expected to result in period lengthening.
In DD, however, vigabatrin produced no change in the circadian period. Thus, GABA may not be involved primarily in the generation of rhythms, as suggested from studies of GABA effects on the SCN in vitro ). This role is not ruled out by the present findings, since the induced changes in GABA levels, which were not measured directly, may not have been sufficient to affect the free-running oscillator in DD measurably. Nonetheless, taken together, the results of our experiments indicate a primary role for GABA in regulating the responsiveness of the circadian system to light rather than in rhythm generation. Perhaps the most interesting finding in these experiments was that the effects of vigabatrin were clearly phase-dependent, causing changes only in early-night responses to light. This result is consistent with data obtained in earlier pharmacological studies, which demonstrated phase-dependent effects of GABA active agents. Bicuculline attenuated phase delays but not advances Menaker, 1985, 1989) , and benzodiazepines blocked phase advances but not delays Menaker, 1986, 1989) . These findings, when taken together with the present data, support the general conclusion that GABA activity plays a role in photic entrainment, regulating perhaps the relative magnitude of photic responses in the early and late subjective night.
The data add to a growing body of literature suggesting that the biochemical mechanisms responsible for light-induced phase shifts are different in the early and late subjective night. Agents that affect GABA neurotransmission in particular seem to differentiate between delay and advance responses. A general model that explains many of these results suggests that phase dependence arises due to an endogenous rhythm of GABA activity that influences the apparent efficacy of pharmacological agents (Ralph and Menaker, 1989) . Still, a number of discrepancies remain to be explained. In particular, the lack of effectiveness of picrotoxin and the relative insensitivity of the circadian system to GABA agonists (Ralph and Menaker, 1989) suggest that the classic mechanisms of GABA action, increasing chloride conductance, may not be the sole effector mechanism for these drugs. This possibility is emphasized by comparing the effects of diazepam and vigabatrin, both of which should potentiate GABA activity but through different routes. Whereas diazepam reduces light-induced advances but not delays (Ralph and Menaker, 1986) , vigabatrin increases delays but not advances. The simplest explanation for the difference may be that diazepam has effects at GABA-benzodiazepine receptors in addition to potentiating GABA activity, and that the receptor complex itself mediates a number of modulatory actions on photic responsiveness.
In addition, pharmacological manipulations in general require some caution in the interpretation of results. In the present experiments, the use of intraperitoneally delivered vigabatrin might raise the possibilities that (1) the site of action is not the SCN, and (2) the mechanism of action is not GABA potentiation. As well as inhibiting GABA transaminase, vigabatrin may decrease glutamic acid decarboxylase (GAD) activity (Perry et al., 1979) , thus balancing the effects on GABA levels. However, this latter finding depends on the type and duration of treatment (Neal and Shah, 1990) . Vigabatrin also decreases excitatory amino acid (EAA) levels (Halonen et al., 1990 (Halonen et al., , 1991 Kalviainen et al., 1993; Loscher and Horstermann, 1994) , thereby potentially decreasing the photic input to the circadian clock (Colwell et al., 1990; Colwell and Menaker, 1992; Rea et al., 1993) . However, if the drug were acting primarily through decreasing EAA transmission, one would expect an effect on both phase delays and phase advances of the circadian rhythm, and decreases rather than increases in response would be predicted. Similarly, effects of vigabatrin on neuroendocrine function (Jung, 1982) and behavior (Palfreyman et al., 1981) do not explain the phase FIGURE 6. Period changes in animals chronically treated with vigabatrin in LL (*p < 0.03 during treatment vs. pretreatment condition [vigabatrin group], Student's t test). dependence of its effects on clock responses. Moreover, locomotor activity levels were not significantly affected by the acute or chronic vigabatrin treatments at the doses employed in the present work, making it unlikely that the effects might be activity-related.
Consequently, although peripherally administered vigabatrin may have effects on many sites (e.g., retina, Neal et al., 1989 ; IGL, Moore and Speh, 1993) and on numerous biochemical mechanisms, the most parsimonious interpretation of the results obained is that the drug increases the influence of GABA on responses to light, and that phase dependence is due to endogenous changes in GABA release. In an LD cycle, GABA uptake in the SCN decreases at light onset (Barkai et al., 1985) , whereas its content (Aguilar-Roblero et al., 1993) or turnover (Kanterewicz et al., 1993) peaks in the night hours. If GABA activity is particularly high at activity onset (associated with light offset in LD conditions), then the manipulation of its levels would have maximal effect at this time. GABA in the SCN appears to be involved in regulating the relative responsiveness of the circadian system to light in the early subjective night. As such, its primary role in nature may be to participate in determining the phase relationship between an animal's internal clock and the local LD cycle. 
